These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 261582)

  • 61. [The use of spectroscopic methods for the detection of drug sorption in polyethylene containers. 15. The problem of synthetic container inserts for liquid drug preparations].
    Senf HJ; Wollmann H
    Pharmazie; 1975 May; 30(5):301-3. PubMed ID: 1178739
    [No Abstract]   [Full Text] [Related]  

  • 62. Particulate matter in I.V. infusion fluids.
    Davis NN; Turco S; Sivelly E
    Bull Parenter Drug Assoc; 1970; 24(6):257-70. PubMed ID: 5495399
    [No Abstract]   [Full Text] [Related]  

  • 63. The microbial contamination of intravenous infusions during clinical use.
    Holmes CJ; Allwood MC
    J Appl Bacteriol; 1979 Apr; 46(2):247-67. PubMed ID: 110761
    [No Abstract]   [Full Text] [Related]  

  • 64. Selection of plastic containers for pharmaceuticals.
    Homrowski S
    Polim Med; 1977; 7(2):91-7. PubMed ID: 600885
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Update on particulate contamination of commercial antibiotics.
    Masuda JY; Beckerman JH
    Am J Hosp Pharm; 1973 Apr; 30(4):297. PubMed ID: 4697651
    [No Abstract]   [Full Text] [Related]  

  • 67. Visible particle limits in small volume parenterals.
    Leelarasamee N; Howard SA; Baldwin HJ
    J Parenter Drug Assoc; 1980; 34(3):167-74. PubMed ID: 6901772
    [No Abstract]   [Full Text] [Related]  

  • 68. Some factors influencing the measured content of particulate matter in infusion fluids.
    Ernerot L; Helmstein I; Sandell E
    Acta Pharm Suec; 1970 N0v; 7(5):501-8. PubMed ID: 5275181
    [No Abstract]   [Full Text] [Related]  

  • 69. Letter: Contaminated intravenous infusions.
    Tenney JH; Dixon RE; Bennett JV
    Lancet; 1974 Apr; 1(7859):679. PubMed ID: 4132343
    [No Abstract]   [Full Text] [Related]  

  • 70. Aluminum in large and small volume parenterals used in total parenteral nutrition--FDA. Proposed rule.
    Fed Regist; 1998 Jan; 63(2):176-85. PubMed ID: 10176836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An insertable orifice tube for in situ contamination counts of solutions in opened ampoules and vials using the Coulter Counter.
    Lines RW
    J Pharm Pharmacol; 1967 Oct; 19(10):701-2. PubMed ID: 4383589
    [No Abstract]   [Full Text] [Related]  

  • 72. Panel discussion: particulate matter. I. Prevention.
    Chertkoff MJ
    Bull Parenter Drug Assoc; 1966; 20(2):29-30. PubMed ID: 5905223
    [No Abstract]   [Full Text] [Related]  

  • 73. [Study on particle contamination produced by syringe needles and rubber stoppers for pharmaceutical solutions].
    Zhao L; Wang HS; Han ZF
    Zhonghua Hu Li Za Zhi; 1997 Jan; 32(1):12-4. PubMed ID: 9304949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Panel discussion: particulate matter. 3. Electronic inspection.
    Levine S
    Bull Parenter Drug Assoc; 1966; 20(2):33-4. PubMed ID: 5905225
    [No Abstract]   [Full Text] [Related]  

  • 75. Evaluation and training for a parenteral inspection machine.
    Varsano J
    Bull Parenter Drug Assoc; 1969; 23(4):186-98. PubMed ID: 5797801
    [No Abstract]   [Full Text] [Related]  

  • 76. Two methods of single-dose ampule opening and their influence upon glass particulate contamination.
    Giambrone AJ
    AANA J; 1991 Jun; 59(3):225-8. PubMed ID: 1950400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Re: 'Relationship between Length of Time and Contamination in Open Intravenous Solutions'.
    McGrory A
    Nurs Res; 1979; 28(5):281. PubMed ID: 257404
    [No Abstract]   [Full Text] [Related]  

  • 78. [New cleanliness assessement for particulate matters in large-volume parenteral injection].
    Tsuji S; Isaka H
    Yakugaku Zasshi; 1987 Mar; 107(3):238-44. PubMed ID: 3598875
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluation of the Royco 367 small volume sample feeder for estimation of particulate contamination in ampoules [proceedings].
    Davies PJ; Smart JD
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():108P. PubMed ID: 42681
    [No Abstract]   [Full Text] [Related]  

  • 80. Specification of limits for particulate contamination in pharmaceutical dosage forms.
    Hailey DM; Lea AR; Kendall CE
    J Pharm Pharmacol; 1982 Oct; 34(10):615-20. PubMed ID: 6128382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.